SMS Pharmaceuticals Ltd — Major Shareholding Notification 2020

Jun 22, 2020

Registered & Corporate Office: Plot No. 72. H. No. 8-2-334/3 & 4. Road No.5. Opp. SBI Executive Enclave. Banjara Hills. Hyderabad - 500 034. Telangana. INDIA. Tel: +91-40-25259999. Fax: +91-40-25259889 CIN : L24239TG1987PLC008066 Email: info@smspharma.com, www.smspharma.com

Date: 220d June, 2020

To,

The Manager, Corporate Filings Department, BSE Lim ited, Phiroze Jeejeebhoy Towers, Da la I Street, Mumbai- 400 001

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/l, G Block, Bandra-Kurla Complex, Bandra (E), Mumba i - 400 051.

Security Code: 532815

Symbol : SMSPHARMA

Dear Sir/Madam,

Sub: Intimation received for the proposed acquisition under Regulation 10(5) of the SEBI (SAS1) Regulation, 2011.

We have received the intimation under Regulation 10(5) of SEBI (Substantial Acq uisition Shares Takeovers) Regulations, 2011 for the proposed acq uisition of 26,50,000 ( Twenty six lakhs fifty thousand) Equity sha res (3 .13%) of the Company from the acquirer namely, Mr. Ramesh Babu Potluri to acquire the shares from Mrs. Annapurna Talluri, as inter-se transfer of equity shares between the promoters and promoters group.

This information is submitted to the Stock Exchanges Pursuant to the Regulation 3(ii) of SEBI (Prohibition of Insider Trad ing) Regulations, 2015 as unpublished Price Sensit ive Information (U PSI).

A copy of the intimation letter dated 220d June, 2020 received from the acquirer is attached.

This is for your information and records.

Thanking you,

~ faithfu~ ,

.S~

Co mp any Secretary Encl: a/a

Date: 22.06.2020

From: Ramesh Babu Potluri. Plot No: 265Q, Road No:10 Jubilee Hills Hyderabad - 500 033

To:

Listing Centre/Corporate Relation Department B S E Limited P J Towers, Dalal Street Mumbai: 400001

Scrip Code: 532815 Email: corp.relations@bseindia.com; corp.comm@bseindia.com

The Company Secretary SMS Pharmaceuticals Limited Plot No. 72, H.No: 8-2-334/3 & 4, Road No. 5 Opp. SBI Executive Enclave, Banjara Hills Hyderabad 500034.

Dear Sirs,

Sub: Intimation under Regulation 10(5) of the SEBI (SAST) Regulation, 2011. Ref: Name of the Target Company: SMS Pharmaceuticals Limited - ISIN: INE812G01025

Intimation is hereby given, pursuant to Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011, as amended, (hereinafter referred to "Regulations") that I intend to acquire 26,50,000 (Twenty-six lakhs fifty thousand) equity shares (3.13%) of SMS Pharmaceuticals Limited ("Target Company") on or after 26.06.2020 from Mrs. Annapurna Talluri. The said transaction is an inter-se transfer between members of Promoters/Promoters' Group / Persons acting in concert.

An advance intimation in the prescribed form as required under aforesaid regulation is enclosed herewith for your information and records.

$\mathbf{f}$

Thanking you,

Yours sincerely,

Ramesh Babu Potluri

Encl as above

Asst. Vice President National Stock Exchange of India Limited "Exchange Plaza", Bandra-Kurla Complex Bandra East, Mumbai: 400051

Trading Symbol: SMSPHARMA Email: takeover@nseindia.com

Disclosures under Regulation 10(5) - Intimation to Stock Exchanges in respect of acquisition under
Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

主	Name of the Target Company (TC)		SMS Pharmaceuticals Limited ("Target Company") CIN: 1.24239TG1987PLC008066
$\overline{2}$ .	Name of the acquirer(s)		Ramesh Babu Potluri
3. 4.		Whether the acquirer(s) is/ arc promoters of the TC prior to the transaction. If not, nature of relationship or association with the TC or its promoters Details of the proposed acquisition	Yes Promoter & Promoter Group Persons acting in concert
	g:	Name of the person(s) from whom shares are to be acquired	Annapurna Talluri
	b	Proposed date of acquisition	Any time after 4 (four) working days from the date of this intimation, i.e. on or after Friday, June 26, 2020
	Ċ.	Number of shares to be acquired from each person mentioned in 4(a) above	2650000 Equity Shares
	d	Total shares to be acquired as % of share capital of TC	3.13%
	$\mathbf{c}$	Price at which shares are proposed to be acquired	Rs. 43.05 per share
	$\mathbf{f}$	Rationale, if any, for the proposed transfer	Inter-se transfer of equity shares of SMS Pharmaceuticals Ltd between members of Promoter and Promoter Group Persons acting in concert
5.	Relevant sub-clause of regulation 10(1)(a) under which the acquirer is exempted from making open offer		Regulation 10(1)(a)(ii) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 as amended ("Takeover Regulations, 2011')
6.	If.	frequently traded, volume weighted average market price for a period of 60 trading days preceding the date of issuance of this notice as traded on the stock exchange where the maximum volume of trading in the shares of the TC are recorded during such period.	Rs.43.05 per share (NSE)

$\int_{\mathcal{C}}$

7.	If in-frequently traded, the price as	Not applicable
	determined in terms of clause (e) of sub-regulation (2) of regulation 8.
8.	Declaration by the acquirer, that the acquisition price would not be higher by more than 25% of the price computed in point 6 or point 7 as applicable.	We hereby declare that the acquisition price is not higher by more than 25% of the price computed in Point 6.
9.1	Declaration by the acquirer, that the transferor and transferce have complied / will comply with applicable disclosure requirements in the Chapter $\mathbf{v}$ of Takeover 2011 (corresponding Regulations, provisions of the repealed Takeover Regulations 1997)	We hereby declare that the transferor and transferee have complied /will comply with applicable disclosure requirements in Chapter V of the Takeover Regulations, 2011.
10.	Declaration by the acquirer that all the	We hereby declare that all the conditions specified under
	conditions specified under regulation	Regulation 10(1)(a) of the takeover Regulations, with respect to
	$10(1)(a)$ with respect to exemptions	exemptions have been duly complied with, to the extent
11.	has been duly complied with.	applicable. Before the proposed After the proposed transaction
	Shareholding details	transaction
		No. of shares/Voting rights	% w.t.t. total share capital of TC.	No. of shares/Voting rights	% w.r.t. total share. capital of TC
	Acquirer(s) and PACs (other than a. sellers)(*)	41106330	48.56%	43756330	51.69
	b. Seller (s)	15859020	18.73%	13209020	15.60

$\bar{\Lambda}$

$\int_{\mathcal{P}}$ RAMESH BABU POTLURI
Promoter of Target Company

$\bar{\rm h}$

$\hat{p}$

Date: 22.06.2020
Place: Hyderabad